Asian press release distribution

Press Releases for Tuesday, December 2, 2025

Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025 23:01 HKT/SGT

NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI 22:43 HKT/SGT

Fujitsu develops new technology to support human-robot collaboration 22:26 HKT/SGT

OpenAI Joins the Global Anti-Scam Alliance as Foundation Member to Strengthen Global Response Against AI-Enabled Scams 22:00 HKT/SGT

Doubleview Provides Cobalt Resource Summary for the Hat Polymetallic Deposit in Advance of Updated MRE and PEA 21:59 HKT/SGT

Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks 21:55 HKT/SGT

OpenAI以創始成員身份加入全球反詐聯盟，強化全球對抗AI驅動詐騙的應對能力 21:00 HKT/SGT

OpenAI以创始成员身份加入全球反诈骗联盟，强化全球应对人工智能驱动型诈骗的能力 21:00 HKT/SGT

OpenAI Joins the Global Anti-Scam Alliance as Foundation Member to Strengthen Global Response Against AI-Enabled Scams 21:00 HKT/SGT

Digital Realty and BW Digital Partner to Support Expansion of Cross-Border Connectivity Between Singapore and Batam 15:49 HKT/SGT

GEN 宣布針對阿茲海默症及其他神經退化性疾病之試驗藥物 SUL-238 取得全新第一期試驗正面數據 13:00 HKT/SGT

GEN 宣布针对阿尔茨海默病及其他神经退行性疾病的试验性药物 SUL-238 取得新的积极 I 期临床试验数据 13:00 HKT/SGT

GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases 13:00 HKT/SGT

AdipoLABs Opens New Regional Office, Signs Two MoUs With University of Cyberjaya to Advance Healthcare Innovation 12:22 HKT/SGT

君聖泰醫藥公佈HTD1801與達格列淨的頭對頭III期臨床研究結果展現控糖優勢及心血管代謝優效獲益 10:59 HKT/SGT

富士通、偽・誤情報や新たなAIリスクに対応する国際コンソーシアム「Frontria」を創立 10:50 HKT/SGT

君圣泰医药公布HTD1801与达格列净的头对头III期临床研究结果展现控糖优势及心血管代谢优效获益 10:16 HKT/SGT

2025年度論壇「香港數字金融中心建設的機遇與挑戰」暨「跨境金融及金融創新服務大獎」颁獎典禮隆重舉行 09:26 HKT/SGT

ACN Search:

Abdullah Ayed Al Mazny, General Manager at Desert Dragon (ICS Arabia), and Ghufran Hamid, CEO of XDS, at the '10Mw Immersive Cooling for Ai Worlkload' Signing Ceremony on July 8, 2025.


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575